Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Losmapimod in neuropathic pain from lumbosacral radiculopathy
2009-012836-33Phase 2Completed
- Sponsor
- GSK
- Start
- Sep 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Neuralgia and lumbosacral radiculopathy comparing Losmapimod with Placebo (2 arms). Primary endpoint: Change in average daily neuropathic pain score from baseline to Week 5. Started Sep 2009; status: completed.
02
Drugs
losmapimod
03
Conditions
Neuralgialumbosacral radiculopathy
Beyond the preview
Go deeper on 2009-012836-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-012836-33.